Erk1/2 Mouse Monoclonal Antibody

<strong>Erk1/2 Mouse Monoclonal Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2012527_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> ERK1, PRKM3, Mitogen-activated protein kinase 3, MAP kinase 3, MAPK 3, ERT2, Extracellular signal-regulated kinase 1, ERK-1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Estrada CC, Maldonado A, Mallipattu SK. Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities J Am Soc Nephrol. 2019 Feb;30(2):187-200._x000D_ 2: Wei Y, Ren X, Galbo PM Jr, Moerdler S, Wang H, Sica RA, Etemad-Gilbertson B, Shi L, Zhu L, Tang X, Lin Q, Peng M, Guan F, Zheng D, Chinai JM, Zang X. KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target Sci Immunol. 2021 Jul 9;6(61):eabf9792._x000D_ 3: Camorani S, Passariello M, Agnello L, Esposito S, Collina F, Cantile M, Di Bonito M, Ulasov IV, Fedele M, Zannetti A, De Lorenzo C, Cerchia L. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer J Exp Clin Cancer Res. 2020 Sep 7;39(1):180._x000D_ 4: Qi M, Fan S, Huang M, Pan J, Li Y, Miao Q, Lyu W, Li X, Deng L, Qiu S, Liu T, Deng W, Chu X, Jiang C, He W, Xia L, Yang Y, Hong J, Qi Q, Yin W, Liu X, Shi C, Chen M, Ye W, Zhang D. Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models J Clin Invest. 2022 Oct 3;132(19):e157399._x000D_ 5: Wang X, Yang X, Zhang C, Wang Y, Cheng T, Duan L, Tong Z, Tan S, Zhang H, Saw PE, Gu Y, Wang J, Zhang Y, Shang L, Liu Y, Jiang S, Yan B, Li R, Yang Y, Yu J, Chen Y, Gao GF, Ye Q, Gao S. Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6640-6650._x000D_ 6: Negi H, Merugu SB, Mangukiya HB, Li Z, Zhou B, Sehar Q, Kamle S, Yunus FU, Mashausi DS, Wu Z, Li D. Anterior Gradient-2 monoclonal antibody inhibits lung cancer growth and metastasis by upregulating p53 pathway and without exerting any toxicological effects: A preclinical study Cancer Lett. 2019 May 1;449:125-134._x000D_ 7: Wang Y, Fan Z, Xu C, Yan X, Zhou Y, Qiu Z, Yuan Q, Zheng J, Liao Y, Chen X. Anti-ATR001 monoclonal antibody ameliorates atherosclerosis through beta-arrestin2 pathway Biochem Biophys Res Commun. 2021 Mar 12;544:1-7._x000D_ 8: Hattori T, Yamada T, Morikawa H, Marutani T, Tsutsumi K, Nishino K, Shimizu T, Nishi Y, Kiso Y, Mukai H. Generation of monoclonal antibodies against mitocryptide-2: toward a new strategy to investigate the biological roles of cryptides J Pept Sci. 2017 Jul;23(7-8):610-617._x000D_ 9: Nagase Y, Hiramatsu K, Funauchi M, Shiomi M, Masuda T, Kakuda M, Nakagawa S, Miyoshi A, Matsuzaki S, Kobayashi E, Kimura T, Serada S, Ueda Y, Naka T, Kimura T. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer BMC Cancer. 2022 Jun 21;22(1):679._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/19324083">10: Conrad DM, Furlong SJ, Doucette CD, Boudreau RT, Hoskin DW. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation Cell Signal. 2009 Aug;21(8):1298-307. </a>_x000D_ _x000D_ <strong>Products Related to Erk1/2 Mouse Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>